Skip to content

4.8 on G2

Docsie Video to Docs

Free Healthcare Template

Free Clinical Protocol Document Template

Download a free clinical protocol document template in Word, PDF, or Markdown. Or turn any video into clinical protocol document template with Docsie AI — auto-fills every required field.

Study Synopsis Background & Rationale Study Design Eligibility Criteria Study Endpoints Schedule of Assessments Statistical Considerations

Download Word Download PDF Download Markdown

Turn Video Into Clinical Protocol Document Browse Templates

Clinical Protocol Document

Use this template to study protocol for [trial/procedure] with endpoints and assessments.

Template Metadata

Field	Details
Category	Healthcare
Owner	[Team or owner]
Version	[Version number]
Effective Date	[Date]
Review Cycle	[Monthly / Quarterly / Annual / Event-based]
Status	[Draft / In Review / Approved]

Study Synopsis

Protocol title, sponsor, phase, indication, study population, design summary, primary endpoint, and estimated duration in a summary table.

Item	Details	Owner	Status
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]

Notes

[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]

Background & Rationale

Disease background, unmet medical need, mechanism of action of the investigational product, and rationale for the study.

Item	Details	Owner	Status
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]

Notes

[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]

Study Design

Study type (randomized, double-blind, etc.), number of arms, treatment assignment, dosing regimen, visit schedule overview, and study duration.

Item	Details	Owner	Status
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]

Notes

[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]

Eligibility Criteria

Inclusion and exclusion criteria as numbered lists. Be specific about age ranges, lab values, and washout periods.

Item	Details	Owner	Status
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]

Notes

[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]

Study Endpoints

Primary, secondary, and exploratory endpoints with definitions and measurement methods.

Item	Details	Owner	Status
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]

Notes

[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]

Schedule of Assessments

Table showing visits vs. procedures/assessments with timing windows.

Item	Details	Owner	Status
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]

Notes

[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]

Statistical Considerations

Sample size calculation, analysis populations, and primary analysis method.

Item	Details	Owner	Status
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]

Notes

[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]

Safety Reporting

Adverse event definitions, grading scale, reporting timelines, and DSMB oversight. Use Markdown tables for the synopsis, schedule, and eligibility criteria. Include protocol identifiers and version numbers.

Item	Details	Owner	Status
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]
[Item or requirement]	[Describe the relevant detail, evidence, or decision]	[Owner]	[Open / Complete]

Notes

[Add context, assumptions, exceptions, evidence links, screenshots, calculations, or reviewer comments.]

Review and Signoff

Document review conclusions, approvals, unresolved items, and next review date.

Role	Name	Date	Notes
Preparer	[Name]	[Date]	[Notes]
Reviewer	[Name]	[Date]	[Notes]
Approver	[Name]	[Date]	[Notes]

Template Guide

How to Use the Clinical Protocol Document Template

When to Use This Template

Deploy this template when initiating clinical trials requiring regulatory review or IRB/Ethics Committee approval.

Submitting IND applications or clinical trial authorization requests to regulatory agencies
Preparing protocol amendments following study design changes or safety updates
Documenting Phase I-IV studies for pharmaceutical or device investigations

What This Template Covers

This template produces a complete ICH-GCP compliant clinical protocol with regulatory submission components.

Study synopsis table with primary endpoints and estimated enrollment timeline
Schedule of assessments matrix mapping visits to procedures with windows
Statistical analysis plan including sample size justification and analysis populations

Common Pitfalls to Avoid

Most protocol rejections stem from vague endpoints, unrealistic timelines, or incomplete safety monitoring plans.

Missing washout periods in exclusion criteria causes IRB delays or rejections
Undefined adverse event grading scales create inconsistent safety reporting and compliance issues
Omitting protocol version numbers and dates complicates amendment tracking during audits

Template Structure

What the Clinical Protocol Document Template Includes

Use this healthcare template as a starting point, then customize each section to match your internal workflow, evidence, and signoff needs.

1

Study Synopsis

Protocol title, sponsor, phase, indication, study population, design summary, primary endpoint, and estimated duration in a summary table.

2

Background & Rationale

Disease background, unmet medical need, mechanism of action of the investigational product, and rationale for the study.

3

Study Design

Study type (randomized, double-blind, etc.), number of arms, treatment assignment, dosing regimen, visit schedule overview, and study duration.

4

Eligibility Criteria

Inclusion and exclusion criteria as numbered lists. Be specific about age ranges, lab values, and washout periods.

5

Study Endpoints

Primary, secondary, and exploratory endpoints with definitions and measurement methods.

6

Schedule of Assessments

Table showing visits vs. procedures/assessments with timing windows.

7

Statistical Considerations

Sample size calculation, analysis populations, and primary analysis method.

8

Safety Reporting

Adverse event definitions, grading scale, reporting timelines, and DSMB oversight. Use Markdown tables for the synopsis, schedule, and eligibility criteria. Include protocol identifiers and version numbers.

Recommended Structure

Write a Clinical Protocol Document in a formal scientific tone suitable for IRB/Ethics Committee submission. Structure with these sections:

Study Synopsis

Protocol title, sponsor, phase, indication, study population, design summary, primary endpoint, and estimated duration in a summary table.

Background & Rationale

Disease background, unmet medical need, mechanism of action of the investigational product, and rationale for the study.

Study Design

Study type (randomized, double-blind, etc.), number of arms, treatment assignment, dosing regimen, visit schedule overview, and study duration.

Eligibility Criteria

Inclusion and exclusion criteria as numbered lists. Be specific about age ranges, lab values, and washout periods.

Study Endpoints

Primary, secondary, and exploratory endpoints with definitions and measurement methods.

Schedule of Assessments

Table showing visits vs. procedures/assessments with timing windows.

Statistical Considerations

Sample size calculation, analysis populations, and primary analysis method.

Safety Reporting

Adverse event definitions, grading scale, reporting timelines, and DSMB oversight.

Use Markdown tables for the synopsis, schedule, and eligibility criteria. Include protocol identifiers and version numbers.

Example Filled Template

Phase II Clinical Trial Protocol — Cardizem XR for Hypertension Management

Protocol ID: CDZ-HTN-2026-001 | Version: 2.0 | Date: 2026-02-01 Sponsor: Valeant Pharmaceuticals | Phase: II | IND Number: 123456

Study Synopsis

Item	Detail
Title	A Randomized, Double-Blind, Placebo-Controlled Study of Cardizem XR in Stage 1 Hypertension
Population	Adults aged 30-70 with Stage 1 hypertension (SBP 130-139 mmHg)
Design	2-arm, parallel group, 1:1 randomization
Treatment	Cardizem XR 180 mg QD vs. placebo for 12 weeks
Primary Endpoint	Change from baseline in mean 24-hour ambulatory SBP at Week 12
Sample Size	220 subjects (110 per arm)

Background & Rationale

Stage 1 hypertension affects approximately 46% of US adults and is a leading modifiable risk factor for cardiovascular disease. Cardizem XR (diltiazem extended-release) is a calcium channel blocker with established efficacy in moderate-to-severe hypertension. This trial evaluates its benefit-risk profile in the Stage 1 population where lifestyle modification alone is often insufficient.

Eligibility Criteria

Inclusion Criteria

Male or female, aged 30-70 years
Mean seated SBP 130-139 mmHg at screening and baseline visits
Willing to maintain current diet and exercise regimen for study duration
Able to provide written informed consent

Exclusion Criteria

Secondary hypertension of any etiology
eGFR < 60 mL/min/1.73m²
Current use of any antihypertensive medication (2-week washout required)
Known hypersensitivity to diltiazem or dihydropyridine CCBs

Schedule of Assessments

Assessment	Screening	Baseline	Week 4	Week 8	Week 12
Informed consent	X
Vital signs	X	X	X	X	X
24-hr ABPM		X			X
ECG	X				X
Chemistry panel	X		X		X
Adverse events		X	X	X	X

Safety Reporting

All serious adverse events must be reported to the Sponsor within 24 hours. An independent Data Safety Monitoring Board will conduct interim reviews after 50% enrollment. Adverse events are graded per CTCAE v5.0.

Video to Document

Turn Video Into Clinical Protocol Document

Already have a walkthrough or training video covering this process? Skip manual drafting. Upload the video and Docsie AI generates clinical protocol document template with every required field populated — ready for review, signoff, or export.

Generate from Video See Video-to-Docs

Use the template manually, or let Docsie generate the first draft from source footage.

DOCX, PDF, and Markdown downloads

Works with process and training videos

More Healthcare Templates

HIPAA Compliance Procedure

Data handling for [system/process] with PHI rules and breach reporting

Infection Control Protocol

Prevention procedures for [pathogen/setting] with screening and isolation precautions

Lab Test Procedure

Testing procedure for [assay/test] with specimen requirements and QC protocols

Medical Device IFU

Operating instructions for [device] with setup, alarms, and troubleshooting

Patient Care Procedure

Care procedure for [condition/treatment] with milestones and discharge criteria

Pharmacy Compounding Procedure

Compounding process for [medication] with ingredients, equipment, and QC checks

Template FAQ

Clinical Protocol Document Template FAQ

Common questions about downloading and generating a clinical protocol document template.

Using This Template

Q: What is a clinical protocol document template?

A: A clinical protocol document template is a structured document for study protocol for [trial/procedure] with endpoints and assessments.

Q: Is the clinical protocol document template really free?

A: Yes. The clinical protocol document template is completely free to download in Word (DOCX), PDF, and Markdown formats. No signup or credit card required to download.

Q: How do I turn a video into a clinical Protocol Document?

A: Upload a process walkthrough, training recording, or screen capture to Docsie. The AI analyzes the video and generates a complete clinical Protocol Document using this template's structure — every required field auto-filled from the footage.

Q: Can I edit the clinical protocol document template after downloading?

A: Yes. The DOCX format opens in Microsoft Word or Google Docs. The Markdown format imports into Notion, Confluence, Docsie, or any markdown editor. Customize fields, add your branding, and adapt to your internal workflow.